Cargando…

Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients

Background and Objectives: The COVID-19 pandemic has had a considerable impact on inflammatory bowel disease (IBD) patients by limiting their access to medical services due to restrictions and the reorganization of the healthcare systems, which affects their quality of life (QoL). We aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavrilescu, Otilia, Prelipcean, Cristina Cijevschi, Dranga, Mihaela, Popa, Iolanda Valentina, Mihai, Cătălina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146780/
https://www.ncbi.nlm.nih.gov/pubmed/35629979
http://dx.doi.org/10.3390/medicina58050562
_version_ 1784716646950109184
author Gavrilescu, Otilia
Prelipcean, Cristina Cijevschi
Dranga, Mihaela
Popa, Iolanda Valentina
Mihai, Cătălina
author_facet Gavrilescu, Otilia
Prelipcean, Cristina Cijevschi
Dranga, Mihaela
Popa, Iolanda Valentina
Mihai, Cătălina
author_sort Gavrilescu, Otilia
collection PubMed
description Background and Objectives: The COVID-19 pandemic has had a considerable impact on inflammatory bowel disease (IBD) patients by limiting their access to medical services due to restrictions and the reorganization of the healthcare systems, which affects their quality of life (QoL). We aimed to assess the impact of the COVID-19 pandemic on the QoL of patients with IBD. Materials and Methods: We conducted a descriptive observational study, which included 90 adult patients diagnosed with IBD. The study sample consisted of two subgroups: a retrospective-pre-pandemic group (group A) and a prospective-pandemic group (group B). Group A included 45 IBD patients who were evaluated in 2018. Group B included 45 patients with confirmed diagnosis of IBD, evaluated between June and December 2021—the period of the COVID-19 pandemic (prospective), consecutively recruited. All the patients filled in a QoL assessment questionnaire—IBDQ-32. Subsequently, the two samples were comparatively assessed. Results: The average values of the IBDQ scores were significantly lower in 2021 compared to those recorded in 2018: 145.56 vs. 128.3 (p < 0.05). We also we found significant differences between the subscores: IBDQ1 (p = 0.043), IBDQ2 (p = 0.034), IBDQ3 (p = 0.045), IBDQ4 (p = 0.025). Conclusions: IBDQ scores were significantly lower in 2021 compared to 2018 (p < 0.05), showing that during the COVID-19 pandemic, patients with IBD had a more influenced QoL.
format Online
Article
Text
id pubmed-9146780
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91467802022-05-29 Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients Gavrilescu, Otilia Prelipcean, Cristina Cijevschi Dranga, Mihaela Popa, Iolanda Valentina Mihai, Cătălina Medicina (Kaunas) Article Background and Objectives: The COVID-19 pandemic has had a considerable impact on inflammatory bowel disease (IBD) patients by limiting their access to medical services due to restrictions and the reorganization of the healthcare systems, which affects their quality of life (QoL). We aimed to assess the impact of the COVID-19 pandemic on the QoL of patients with IBD. Materials and Methods: We conducted a descriptive observational study, which included 90 adult patients diagnosed with IBD. The study sample consisted of two subgroups: a retrospective-pre-pandemic group (group A) and a prospective-pandemic group (group B). Group A included 45 IBD patients who were evaluated in 2018. Group B included 45 patients with confirmed diagnosis of IBD, evaluated between June and December 2021—the period of the COVID-19 pandemic (prospective), consecutively recruited. All the patients filled in a QoL assessment questionnaire—IBDQ-32. Subsequently, the two samples were comparatively assessed. Results: The average values of the IBDQ scores were significantly lower in 2021 compared to those recorded in 2018: 145.56 vs. 128.3 (p < 0.05). We also we found significant differences between the subscores: IBDQ1 (p = 0.043), IBDQ2 (p = 0.034), IBDQ3 (p = 0.045), IBDQ4 (p = 0.025). Conclusions: IBDQ scores were significantly lower in 2021 compared to 2018 (p < 0.05), showing that during the COVID-19 pandemic, patients with IBD had a more influenced QoL. MDPI 2022-04-19 /pmc/articles/PMC9146780/ /pubmed/35629979 http://dx.doi.org/10.3390/medicina58050562 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gavrilescu, Otilia
Prelipcean, Cristina Cijevschi
Dranga, Mihaela
Popa, Iolanda Valentina
Mihai, Cătălina
Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title_full Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title_fullStr Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title_full_unstemmed Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title_short Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
title_sort impact of covid-19 pandemic on the quality of life of ibd patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146780/
https://www.ncbi.nlm.nih.gov/pubmed/35629979
http://dx.doi.org/10.3390/medicina58050562
work_keys_str_mv AT gavrilescuotilia impactofcovid19pandemiconthequalityoflifeofibdpatients
AT prelipceancristinacijevschi impactofcovid19pandemiconthequalityoflifeofibdpatients
AT drangamihaela impactofcovid19pandemiconthequalityoflifeofibdpatients
AT popaiolandavalentina impactofcovid19pandemiconthequalityoflifeofibdpatients
AT mihaicatalina impactofcovid19pandemiconthequalityoflifeofibdpatients